Skip To Main Content { "isEditMode": false, "isPublic": true, "context": "", "site": "campus-sanofi-th", "currentLocale": "en_TH", "translationsPath": "" } [{ event: `metadata`,device: /(tablet|ipad|playbook|silk)|(android(?!.*mobi))/i.test(navigator.userAgent) ? 'tablet' : (/Mobile|iP(hone|od)|Android|BlackBerry|IEMobile|Kindle|Silk-Accelerated|(hpw|web)OS|Opera M(obi|ini)/.test(navigator.userAgent) ? 'mobile' : 'desktop'),platform: `magnolia`,language: `en`,siteType: `advise`,brandWebsiteType: `multibrand`,region: `apac`,country: `thailand`,target: `hcp`,brand: `Multi-Brand`,gbu: `Cross bu`,pageName: `Sitemap` }] This website is intended exclusively for the healthcare professionals residing and/or working in Thailand.
Sitemap
- Cookie Policy - Cookie Policy
- Terms of Use - Terms of Use
- Email & Phone subscription PDPN
- My Account
- Science
- Cutting Edge Science
- Benign Prostate Hyperplasia (BPH)
- Neurology
- Cardiovascular
- Central Nervous System
- Chronic Kidney Disease
- Consumer health
- Diabetes
- Thrombosis
- Vaccines
- Childhood
- Choosing Hexavalent Vaccine, a globally trusted aP vaccine. Offer the safety, e cacy, consistency & reliability of an ap vaccine.
- Choose aP vaccines for improved parents' satisfaction
- aP vs wP pertussis vaccines
- A randomized open-label trial Of 2-Dose or 3-Dose pre-exposure Rabies Prophylaxis among Thai children
- Hexavalent Vaccine is an Acellular Pertussis (aP) Vaccine based on highly purified, selected components of Bordetella Pertussis organisms.
- Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP~T vaccination at 2, 4 and 6 months¹
- A time and motion study of the fully-liquid hexavalent vaccine.
- Switching from wP to aP pertussis vaccine
- aP vs wP pertussis vaccines
- A time and motion study.
- Burden of Respiratory Syncytial Virus Infection During the First Year of Life.
- Economic Assessment of Incorporating the Hexavalent Vaccine as Part of the National Immunization Program of Peru
- Bordetella pertussis is a common pathogen in infants hospitalized for acute lower respiratory tract infection during the winter season
- Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States
- Maternal Vaccination and Infant Influenza and Pertussis
- Rates and risk factors of severe respiratory syncytial virus infection in 2008-2016 compared with 1986-1998
- Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations.
- Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022
- Rabies-Related Knowledge, Attitudes, and Practices among Primary School Students in Chonburi Province, Thailand
- Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in Southeast England, 2019
- Predominant role of Haemophilus influenzae in the association of conjunctivitis, acute otitis media and acute bacterial paranasal sinusitis in children.
- Cost-minimization and opportunity cost analysis of fully-liquid hexavalent and meningococcal vaccines in Spain
- Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China
- Prescribe with simplify schedule by choosing hexavalent Vaccine
- Vaccine Effectiveness against Pediatric Influenza-a-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, Vision Network
- Influenza Vaccination in Children with Pulmonary Disease During the Covid-19 Pandemic
- Inpatient Burden of Respiratory Syncytial Virus in Children ≤2 Years of Age in Germany: A Retrospective Analysis of Nationwide Hospitalization Data, 2019-2022
- Inpatient Burden of Respiratory Syncytial Virus in Children ≤2 Years of Age in Germany: A Retrospective Analysis of Nationwide Hospitalization Data, 2019-2022
- Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease in Children. Statement of the Spanish Society of Paediatric Infectious Disease (Seip)
- Effectiveness of Poliovirus Vaccines against Circulating Vaccine-Derived Type 2 Poliomyelitis in Nigeria between 2017 and 2022: A Case-Control Study
- Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children
- Cost-Effectiveness of Seasonal Influenza Vaccination of Children in China: A Modeling Analysis
- The Impact of Rsv Hospitalization on Children's Quality of Life
- Persistence of Antibodies 5 Years after Hepatitis B Vaccination in Preterm Birth Children: A Retrospective Cohort Study Using Real-World Data
- Uncovering the Burden of Influenza in Children in Portugal, 2008-2018
- Seroprevalence of Hepatitis A Virus Antibodies among Children and Adolescents Living in Northern Thailand: An Implication for Hepatitis A Immunization
- Influenza Vaccine Effectiveness among Children: 2011-2020
- Nirsevimab for Prevention of Hospitalizations Due to Rsv in Infants
- What is the benefit of the acP vaccine?
- Choose aP vaccinesto improve parent's satisfaction
- Effectiveness of Poliovirus Vaccines against Circulating Vaccine-Derived Type 2 Poliomyelitis in Nigeria between 2017 and 2022: A Case-Control Study
- Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- General
- Influenza
- WHO recommended composition of influenza virus vaccines for use in the 2024 southern hemisphere
- In patients with respiratory disease. Flu can have a devastating impact¹, ²
- Influenza vaccine in heart failure patients
- WHO recommended composition of influenza virus vaccines for use in the Northern hemisphere 2022-2023
- Influenza vaccine in the patients with CVD
- Influenza vaccination is cost-effectiveness
- WHO recommended composition of influenza virus vaccines for use in the 2023 northern hemisphere
- WHO recommended composition of influenza virus vaccines for use in the Northern hemisphere 2023-2024
- The impact of influenza vaccination on cardiovascular disease
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- High-Dose Influenza Vaccine in Older Adults by Age and Seasonal Characteristics: Systematic Review and Meta-Analysis Update
- Enhanced Passive Safety Surveillance of High-Dose and Standard-Dose Quadrivalent
- Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Influenza Vaccination and Risk of Stroke in Women with Chronic Obstructive Pulmonary Disease: A Nationwide, Population-Based, Propensity-Matched Cohort Study
- High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 years: Can We Do Better? A Systematic Literature Review
- A Pragmatic Randomized Feasibility Trial of Influenza Vaccines
- The impact of influenza vaccination on cardiovascular disease
- Influenza Vaccination and Hospitalization Outcomes Among Older Patients With Cardiovascular or Respiratory Diseases
- How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population
- Influenza circulating viruses, positivity rate and risk factors for influenza associated severe acute respiratory infection during 2018/2019 winter season, Yemen
- A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections
- Global, Regional and National Estimates of Influenza-Attributable Ischemic Heart Disease Mortality
- Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics
- Correlation between Cardiovascular Protection and Influenza Vaccination
- High-Dose Influenza Vaccine Is Associated with Reduced Mortality among Older Adults with Breakthrough Influenza Even When There Is Poor Vaccine-Strain Match
- Burden of Influenza in the Elderly: A Narrative Review
- Cost-Effectiveness of Influenza Vaccination with a High Dose Quadrivalent Vaccine of the Elderly Population in Belgium, Finland, and Portugal
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- Influenza Vaccination after Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease
- Influenza Vaccination Blunts the Inflammatory Response in Patients Undergoing Cardiopulmonary Bypass
- Global Burden of Influenza Lower Respiratory Tract Infections in Older People from 1990 to 2019
- Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
- Cost-Effectiveness of High-Dose Quadrivalent Influenza Vaccine Versus Standard-Dose Quadrivalent Influenza Vaccine for Older People in a Country with High Influenza Vaccination Rate
- Influenza Vaccination for Elderly, Vulnerable and High-Risk Subjects: A Narrative Review and Expert Opinion
- Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan
- Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study.
- The Association between Influenza Vaccine and Risk of Chronic Kidney Disease/Dialysis in Patients with Hypertension
- Estimated Health and Economic Impact of Using High-Dose Influenza Vaccine on Respiratory and Circulatory Plus Respiratory Hospitalizations of Older Adults in Australia
- Effectiveness of Influenza Vaccination against Coronavirus Disease (Covid)-19 Outcomes in Hospitalized Individuals in Brazil: An Epidemiological Study
- A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections
- Dialysis Patients Respond Adequately to Influenza Vaccination Irrespective of Dialysis Modality and Chronic Inflammation
- Influenza Vaccination and Major Cardiovascular Risk: A Systematic Review and Meta-Analysis of Clinical Trials Studies
- Smoking Cessation and Influenza Vaccination Can Reduce the Healthcare Burden of Copd
- Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
- Cardiologists' Knowledge and Perceptions of the Seasonal Influenza Immunisation
- Cardioprotective Effects of Influenza Vaccine
- Influenza Vaccination in Older Adults and Patients with Chronic Disorders: A Position Paper from the Portuguese Society of Pulmonology, the Portuguese Society of Diabetology, the Portuguese Society of Cardiology, the Portuguese Society of Geriatrics and Gerontology, the Study Group of Geriatrics of the Portuguese Society of Internal Medicine, and the Portuguese Society of Infectious Diseases and Clinical Microbiology
- Immunogenicity and Reactogenicity of Coadministration of Covid-19 and Influenza Vaccines
- Effectiveness of High-Dose Vs. Standard-Dose Quadrivalent Influenza Vaccine against Recurrent Hospitalisations and Mortality in Relation to Influenza Circulation: A Post-Hoc Analysis of the Danflu-1 Randomised Clinical Trial
- Impact of Influenza Vaccination History in the Clinical Course of Older Adults Hospitalized with Covid-19
- Rates of Severe Influenza-Associated Outcomes among Older Adults Living with Diabetes-Influenza Hospitalization Surveillance Network (Flusurv-Net), 2012- 2017
- Efficacy and Prolonged Safety of Haemophilus Influenzae Type B Conjugate Vaccines
- Summary of the National Advisory Committee on Immunization (Naci) Statement-Recommendation on Repeated Seasonal Influenza Vaccination
- Effect of influenza on outcomes in patients with heart failure.
- WHO recommended composition of influenza virus vaccines for use in 2024-2025 northern hemisphere
- Influenza Vaccine Effect on Risk of Stroke Occurrence: A Systematic Review and Meta-Analysis
- Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- Enhanced Passive Safety Surveillance of High-Dose and Standard-Dose Quadrivalent Inactivated Split-Virion Influenza Vaccines in Germany and Finland During the Influenza Season 2021/22
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Safeguard your whole family Standard dose for child & adult & High-dose vaccine for seniors 65+
- Pregnancy
- Rare Diseases
- Events
- Take a break
- Patient Support
- Disclaimer
- Error 404
.jpg/jcr:content/image%20(17).jpg)
